Skip to content

Clinical trials

Fabry Disease trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Country / region: Austria Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20091
20112
20131
20151
20182
20191
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amicus Therapeutics2
CENTOGENE GmbH Rostock2
Genzyme, a Sanofi Company2
Idorsia Pharmaceuticals Ltd.2
Sanofi2
Chiesi Farmaceutici S.p.A.1
Klinikum Wels-Grieskirchen1
Medical University of Vienna1
Shire1
Spur Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease15
Lysosomal Storage Diseases2
Stroke2
Hypertrophy1
Hypertrophy, Left Ventricular1
Renal Insufficiency, Chronic1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.